Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01421524
Title Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene Corporation
Indications

non-Hodgkin lymphoma

hepatocellular carcinoma

glioblastoma

multiple myeloma

gliosarcoma

diffuse large B-cell lymphoma

Therapies

CC-122

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | BEL


No variant requirements are available.